Leverage Shares - 2x Apple
AAP2.L
London Stock Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Leverage Shares 2x Apple ETC A (AAP2.L) is an exchange-traded product (ETP) issued by Leverage Shares Public Limited Company that provides two times (2x) the daily performance of Apple Inc. (AAPL) stock. The ETP tracks the NYSE Leveraged 2x AAPL Index through physical replication by investing directly in Apple shares and using margin borrowing from providers such as Interactive Brokers LLC and/or Morgan Stanley & Co. LLC to achieve the leveraged exposure; it features an intraday rebalance mechanism known as the "airbag" to cushion large intra-day falls, trades like an equity on exchanges with multiple market makers, and carries an annual management fee of 0.75% alongside an ongoing charge of 1.75%. Launched on December 5, 2017, and domiciled in Ireland with ISIN XS2820605157, the ETP is listed primarily on the London Stock Exchange (LSE) in USD (AAP2), GBP (2AAP), and EUR (AAPE) tranches, and is available for sale in countries including the United Kingdom, Italy, Germany, France, Spain, Netherlands, Ireland, Poland, and Belgium. Leverage Shares Public Limited Company, founded in 2017 and headquartered in Dublin, Ireland, operates as a pioneer in leveraged and inverse ETPs offering exposure to single stocks, indices, ETFs, and commodities across European and U.S. exchanges, with over 160 products and approximately $1.5 billion in assets under management as of September 2025. In recent developments, the issuer expanded aggressively with 19 new ETPs launched on the LSE in September 2025, including first-ever 3x leveraged products on stocks such as Robinhood (HOOD), Hims & Hers (HIMS), UnitedHealth (UNH), Intel (INTC), Broadcom (AVGO), ASML, and Eli Lilly (LLY), alongside 5x long/short on FTSE 100 and FTSE MIB indices and a white-label Pantarai ADAPT ETP; earlier in January 2025, Leverage Shares by Themes introduced U.S.-listed 2x long ETFs on ASML (ASMG), ARM (ARMG), and TSM (TSMG) on Nasdaq, followed by nine additional single-stock leveraged ETFs in November 2025, bringing the total to 43 such products. These launches reflect record trading growth, with year-to-date turnover through August 2025 up 86% versus 2024 and average monthly trading up nearly 50% year-over-year, underscoring the firm's strategic focus on meeting demand for higher-leverage and inverse exposures amid volatile markets.